河北医科大学学报

• 论著 • 上一篇    下一篇

复方甘草酸苷在卵巢癌患者术后辅助化疗效果的临床研究

  

  1. 1.河北省沧州市中心医院妇一科,河北 沧州 061000;2.河北医科大学第四医院妇科,河北 石家庄 050011
  • 出版日期:2016-03-25 发布日期:2016-05-11
  • 作者简介:黄平( 1978- ),女,河北沧州人,河北省沧州市中心 医院主治医师,医学硕士,从事妇科疾病诊治研究。

Clinical study of effects of compound glycyrrhizin on postoperative adjuvant chemotherapy in ovarian cancer patients

  1. 1.Depatment of Gynaecology and Obstetric, the Central Hospital of Cangzhou City, Hebei Province,
    Cangzhou 061001, China; 2.Depatment of Gynaecology and Obstetric, the Fourth Hospital
    of Hebei University, Shijiazhuang 050011, China
  • Online:2016-03-25 Published:2016-05-11

摘要: [摘要] 目的 探讨甘草酸在妇科晚期恶性卵巢癌患者术后化疗过程中减少不良反应、改善临床症状及保护
肝功能的作用。方法 选择卵巢癌患者 60 例,随机分为观察组和对照组各 30 例,均采用紫杉醇、卡铂化疗方案:紫
杉醇 60~90mg / m
2 ,第 1 、
8 、 15 天;卡铂( AUC=5 ),第 1 天。观察组于化疗日起给予复方甘草酸苷注射液 60mL
加入 10% 葡萄糖溶液 250mL 中静脉滴注, 1 次/ d ,连续 10d ,之后改服用复方甘草酸苷片 150mg /次, 3 次/ d 至下
一疗程开始。观察患者化疗前及化疗 4 周期白细胞、临床症状、肝功能、 T 淋巴细胞及病情预后变化。结果 观察
组与对照组在白细胞降低发生率、化疗后临床症状变化发生率、纠正肝功能异常以及 CD3
+ 、 CD4 + 、 CD8 + 、
CD4
+ /
CD8
+ 变化方面差异均有统计学意义(
P <0.05 )。结论 复方甘草酸苷能使卵巢癌患者化疗期间不良反应、
临床症状及免疫抑制得以明显改善,能有效纠正卵巢癌患者化疗期间出现的肝功能异常,对肿瘤预后无影响。

关键词: 卵巢肿瘤, 甘草酸, 放化疗, 辅助

Abstract: [
Abstract ] Objective Toinvestigatetheeffectsofglycyrrhizicacidinreducingtheside
effects , improving clinical symptoms and protecting liver function in the patients with
gynecologicmalignantovariancancerafterchemotherapy.Methods A totalof60casesof
patientswithovariancancerwererandomlydividedinto2groups : theobservationgroup ( n =30 )
andthecontrolgroup ( n =30 ) .Thepaclitaxel ( Toxal160-90 mg
/ m
2 ,
Day1 , 8 , 15 ) and
carboplatin ( Carbo [ AUC=5 ], Day1 ) wereusedintwogroups.Thechangesofclinicalindexes
intwogroupswerestudiedafter4cyclesofchemotherapy.Thetreatmentgroupwasgivenwith
compoundglycyrrhizininjection ( 60 mLin10% glucosesolution250 mLintravenousinfusion ,
onetimeperdayfor10consecutivedays ), thentakingcompoundglycyrrhizintablet ( 150mgone
time , 3timesoneday ) .Thechangesofleukocytes , clinicalsymptoms , liverfunction , CD3
+ ,
CD4
+ ,
CD8
+ ,
CD4
+ /
CD8
+
andprognosisinpatientsbeforeandafter4cyclesofchemotherapy
weremonitored.Results There weresignificantdifferencesintheincidenceofleukopenia ,
improvingtheabnormalliverfunction , theclinicalsymptomsandchangesofCD3
+ , CD4 + ,
CD8
+ ,
CD4
+ /
CD8
+
betweentwogroups ( P <0.05 ) .Conclusion Compoundglycyrrhizincan
improvethesidereaction , liverfunction , clinicalsymptomsandimmunosuppressioninovarian
cancerpatientsduringchemotherapy.However , ithasnoeffectontumorprognosis.

Key words: ovarianneoplasms , glycyrrhizicacid ;
chemoradiotherapy,
adjuvant